 Why its needed?

 What is advantage by prolonging drug action?

 How to prolong?

 Any clinical significance in prolonging action?

 Advantages :-
 Reduces frequency of adm -more convenient
 Improves patient compliance-
 single morning dose can’t be forgotten than a 6 or
8hly regimen (multiple dosing).
 Quarterly administered contraceptive over one that
has take daily.
 Avoids large Plasma fluctuations.
 Maintains drug effect for the whole day/night.
e.g.. Antiasthmatics & anticonvulsants.
 Drugs need not to be made long acting-

 Drugs with brief therapeutic effect-hypnotics &

head ache remedy.

 Drugs with long duration- doxycyclin, omeprazole,

digoxin & amlodipine.

 Drugs with longer t1/2 > 12hr- no need of C.R.F.

C.R.F=controlled release formulation .

Methods to be used for prolongation of a drug:

 By Retarding drug absorption.

 By Retarding drug metabolism in the liver.

 By Retarding drug excretion.

 By using drugs of highly protein bound.

 By modifying the molecular structure of a drug.

1. Retarding drug absorption.
a. Oral Route:-
 Administration of drugs on full stomach.
 Sustained Release Tablets & Spansules.
-Drugs particles are coated with resins, plastic materials or other
Substances - active ingredients released slowly into G.I.T.
 Controlled Release Tab/Cap-
-semipermeable membrane control the release of active drug from
dosage form.
-prolongs actions by 4 to 8hrs & safely reaches the colon.
- drug release pattern & maintenance of plasma levels are different with
normal Tab/cap.
b)Parenteral Route–
1. By decreasing the vascularity of absorbing surface.
e.g. Adrenaline + lignocaine/procaine.
2.By decreasing the solubility of drug.
E.g. penicillin + procaine(poor H2O soluble solvent)&
Benzocaine
3.Administration of drug in oily solution/bees wax.
E.g. penicillin + aluminum monosterate (H2O repellant)
Pitressin tannate in oil.
4.Combining a drug with protein.
E.g. Protamine zinc insulin
5. Esterification:-(benzoate,enanthate,propionate)
Steroidal Sex Hormones are esterified with carboxylic acid
which are absorbed slowly.
6.Pegylation:
Combined with poly ethylene glycol
7.Depot Preparation:
e.g. Long acting Progesterone-contraceptive,
DOCA- Addison's disease.
c) Dermal Route:-
1.Pellet implantation -desoxycorticosterone acetate (DOCA)
2.Sialistic and biodegradable implants (Norplant)-oestrogens.
3.Transdermal System-
GTN ointment, Transdermal disc’s,
Patches(estradiol, scopolamine, corticosteroids)
 d) Eye- Ocuserts e.g. pilocarpine for glaucoma
2) Retarding drug metabolism:
Hepatic Microsomal Enzyme system-biotransformation

Enzyme inhibitors- inhibits metabolism of certain drugs.

E.g.

1. Allopurinol inhibits the degradation of 6-MP.

2.Ritonavir boosts the levels of Indinavir.

3.Cilastatin protects Imipinem from degradation in

kidney by dehydropeptidase enzyme

4.L.dopa + carbidopa (dopa decarboxylase inhibitor)

3.Retarding renal excretion:-
 Excretion of drugs by G.F can't be blocked/slowed.

 Tubular secretion of drugs is an active process can be

blocked by competing substance/drugs.
E.g. Ampicillin
Penicillin, Probenecid(blocks OAT)
cephalosporin's, Tubular lumen
sulfa drugs urine

Mtx & Indomethacin penicillin

OAT
Probenecid
4) By increasing protein binding in plasma-

 Drug congeners are prepared with high plasma protein

binding from which active drug is slowly released.

 Long acting sulfonamide- sulfamethoxypyridazine

,sulfodoxin

-highly bound to plasma proteins.

 Short acting sulfonamide- sulfadiazine.

-less bound to plasma proteins.

 Suramin used to RX Trypanosomiasis-

-highly bound to plasma proteins.

 Ptn bounded drug acts as a-
 Drug acceptors
 Drug reservoir
 Pharmacologically inactive
 Prolongs drug duration
 Drug remains in vascular compartment(can’t diffuse thru’ membranes)
 aVd is low(<5L)
 Delays drug metabolism
 Delays drug excretion
 Decreases drug clearance & can’t be removed by hemodialysis.
 Diminishes drug penetration into CNS.
 Responsible for drug displacement interactions(toxicity)
 Attains less conc. In ISF, CSF, tissues-therapeutic activity is low.
E.g- long acting sulfonamides used to Rx diseases
5) Drugs sequestered in adipose tissue-

e.g. Quinestrol - cyclopentyl ester of estradiol have prolonged

drug action.
6) By modifying the molecular structure of a drug-(SAR)
e.g.
Procaine is L.A- on I.V route adm-
- reduces cardiac rate & excitability
- but rapidly hydrolyzed
- hence cardiac action is too transient.
 Procainamide - structurally similar to Procaine
- Resistance to hydrolysis,
- Longer acting RX cardiac arrhythmias.
SAR-Structure activity relationship.
 PROCESSES METHODS EXAMPLES

Absorption Sustained, Spansules, Deriphylline,Iron,

Oral controlled released
formulations

Parenteral 1.Reducing solubility -procaine + penicillin

2.Altering particle size -Insulin zinc suspension(crystalline)
3.Pellet implantation -DOCA
4.Sialistic capsules -Testosterone
5. Reducing vascularity -Adrenaline+Lignocaine
6.Combining with Ptn -Protamine+Znic+Insulin
7.Esterification -Estrogens

Dermal TDS Scopolamine, clonidine, GTN,

pilocarpine
Distribution More Protein binding
drug
Metabolism Cholinesterase inhibitors
peptidase inhibitors
Excretion Competition for same
transporters for T.Secretion
Sulphonamides-
sulfadoxine
-physostigmine+Ach
-Cilastin prolongs action of
Imipenem
-Probenecid prolongs action
of penicillin/ampicillin.
THANK YOU
@$!#*